Search
for
Sort by
Research 481–510 of 1000+
- How should postmenopausal androgen excess be evaluated?
- Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Toward a Diagnostic Score in Cushing's Syndrome
- Metabolic Syndrome and Skin Diseases
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism
- Hidradenitis Suppurativa
- Androgen antagonists in androgen target tissues
- Guidelines for the Use of Acitretin in Psoriasis
- Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines
- TCF/Lef1-Mediated Control of Lipid Metabolism Regulates Skin Barrier Function
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- Medical comorbidities in patients with lichen planopilaris, a retrospective case–control study
- Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata
- Managing polycystic ovary syndrome in primary care
- Metabolic syndrome in androgenic alopecia
- Pharmaceutical and Pharmacological Evaluation of the Effect of Nano-Formulated Spironolactone and Progesterone on Inflammation and Hormonal Levels for Managing Hirsutism Experimentally Induced in Rats
- Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans
- Transcriptome Meta-Analysis Confirms the Hidradenitis Suppurativa Pathogenic Triad: Upregulated Inflammation, Altered Epithelial Organization, and Dysregulated Metabolic Signaling
- Guía clínica chilena para el estudio y tratamiento de hidradenitis supurativa. Resumen ejecutivo
- Towards Best Practice in Hair Metabolomic Studies: Systematic Investigation on the Impact of Hair Length and Color
- Integrated Model of Care for Polycystic Ovary Syndrome
- Inflammatory memory-activated biomimetic nanovesicles regulate neutrophil plasticity and metabolic reprogramming for rapid diabetic wound healing via targeting miR-193a-5p/TLR4/JNK/P38 MAPK pathways
- Bibliometric evaluation of Anais Brasileiros de Dermatologia (2013-2022)
- Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia
- Association of androgenetic alopecia with metabolic syndrome: A case–control study on 100 patients in a tertiary care hospital in South India
- Testosterone Treatment in Women – An Overview
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex